Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$3.62M	-73.90%	-70.50%	-86.63%	2,890.00%	0.05	18.73	60.00%	-49,940.70%	-49,940.74%
VYNE	VYNE THERAPEUTICS INC	$20.23M	-58.20%	-49.60%	-76.47%	-83.50%	0.29	4.35	100.00%	-7,950.90%	-7,950.10%
ROIV	ROIVANT SCIENCES LTD	$8.29B	-4.00%	-3.40%	-3.68%	-9.10%	0.05	37.91	90.90%	-224.70%	-213.29%
PHAT	PHATHOM PHARMACEUTICALS INC	$298.74M	N/A	-92.80%	-89.65%	-54.10%	-2.49	4.20	85.60%	-605.10%	-474.76%
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$41.60M	N/A	-267.80%	-3,314.26%	229.90%	18.08	1.01	N/A	N/A	N/A
ATNM	ACTINIUM PHARMACEUTICALS INC	$47.42M	-96.40%	-45.40%	-55.63%	1,389.10%	1.35	9.14	N/A	N/A	N/A
ELAB	PMGC HOLDINGS INC	$1.62M	-122.80%	-84.70%	-76.60%	-1,065.10%	0.35	3.36	N/A	N/A	N/A
CRVS	CORVUS PHARMACEUTICALS INC	$244.61M	-192.30%	-107.20%	-185.92%	-254.20%	1.12	1.54	N/A	N/A	N/A
VERU	VERU INC	$79.34M	-108.50%	-65.00%	-111.20%	-208.90%	0.50	4.47	31.90%	-260.90%	-252.49%
CNTA	CENTESSA PHARMACEUTICALS PLC	$1.83B	-67.20%	-49.30%	-42.95%	-79.40%	0.44	9.25	N/A	N/A	N/A
GPCR	STRUCTURE THERAPEUTICS INC	$1.55B	-15.70%	-15.10%	-14.09%	-21.10%	0.05	24.74	N/A	N/A	N/A
SAGE	SAGE THERAPEUTICS INC	$456.50M	-69.00%	-60.70%	-84.40%	-79.20%	0.15	9.13	81.40%	-747.60%	-747.61%
BTAI	BIOXCEL THERAPEUTICS INC	$10.15M	N/A	-101.50%	-276.13%	-52.30%	-1.41	1.68	5.40%	-2,630.10%	-1,962.49%
WINT	WINDTREE THERAPEUTICS INC	$4.16M	-65.90%	-18.70%	-7.03%	38.00%	1.47	0.45	N/A	N/A	N/A
RCUS	ARCUS BIOSCIENCES INC	$926.11M	-47.30%	-23.20%	-30.09%	-32.30%	1.37	4.50	100.00%	-109.70%	-107.75%
SVRA	SAVARA INC	$552.43M	-64.50%	-51.20%	-48.39%	-52.50%	0.24	13.73	N/A	N/A	N/A
RPTX	REPARE THERAPEUTICS INC	$58.24M	-44.50%	-38.40%	-55.05%	-78.50%	0.17	6.77	100.00%	-158.40%	-155.67%
HUMA	HUMACYTE INC	$224.92M	N/A	-107.70%	-118.24%	-133.30%	-3.62	2.40	N/A	N/A	N/A
TERN	TERNS PHARMACEUTICALS INC	$288.08M	-30.50%	-29.10%	-25.44%	-60.30%	0.05	23.14	N/A	N/A	N/A
CRGX	CARGO THERAPEUTICS INC	$210.46M	-42.70%	-37.70%	-43.06%	-47.10%	0.15	13.79	N/A	N/A	N/A
CERO	CERO THERAPEUTICS HOLDINGS INC	$4.79M	N/A	-144.50%	646.80%	206.50%	-4.28	0.50	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$252.30M	-35.90%	-33.40%	-37.54%	-49.70%	0.06	24.85	N/A	N/A	N/A
RCKT	ROCKET PHARMACEUTICALS INC	$813.58M	-63.90%	-55.40%	-52.74%	-82.10%	0.14	9.30	N/A	N/A	N/A
FDMT	4D MOLECULAR THERAPEUTICS INC	$156.04M	-28.60%	-26.70%	-30.28%	-40.30%	0.10	14.92	100.00%	-434,778.40%	-434,778.38%
ABCL	ABCELLERA BIOLOGICS INC	$777.75M	-14.90%	-11.60%	-15.61%	-18.20%	0.29	9.81	100.00%	-564.80%	-695.02%
ENVB	ENVERIC BIOSCIENCES INC	$3.26M	-219.70%	-168.20%	-600.58%	-2,127.10%	0.94	1.84	N/A	N/A	N/A
NUVB	NUVATION BIO INC	$762.03M	-125.00%	-97.90%	-117.67%	-111.90%	0.17	9.04	10.10%	-7,213.80%	-7,209.42%
PYXS	PYXIS ONCOLOGY INC	$67.75M	-49.20%	-39.60%	-56.99%	-50.40%	0.30	7.49	97.10%	-478.90%	-492.35%
MNMD	MIND MEDICINE (MINDMED) INC	$481.60M	-48.20%	-37.30%	-40.41%	581.50%	0.25	7.25	N/A	N/A	N/A
SLXN	SILEXION THERAPEUTICS CORP	$8.29M	N/A	-372.10%	1,904.70%	-310.60%	-1.72	0.64	N/A	N/A	N/A
PDSB	PDS BIOTECHNOLOGY CORP	$63.55M	-137.90%	-66.20%	-128.47%	-360.30%	1.39	2.64	N/A	N/A	N/A
CVKD	CADRENAL THERAPEUTICS INC	$30.86M	-202.50%	-156.00%	-143.17%	865.40%	0.36	3.77	N/A	N/A	N/A
IONS	IONIS PHARMACEUTICALS INC	$4.89B	-92.10%	-15.80%	-14.55%	-9.90%	4.91	9.66	98.50%	-63.90%	-51.99%
OCGN	OCUGEN INC	$218.13M	-183.90%	-91.30%	-88.75%	-276.50%	1.78	2.86	100.00%	-1,331.90%	-1,331.94%
MAZE	MAZE THERAPEUTICS INC	$405.11M	-1.00%	2.20%	24.29%	86.70%	-0.14	9.76	100.00%	2.00%	31.88%
GHRS	GH RESEARCH PLC	$496.35M	-20.10%	-19.20%	-21.33%	-35.90%	0.05	17.23	N/A	N/A	N/A
GOVX	GEOVAX LABS INC	$13.98M	-884.90%	-374.10%	-494.62%	2,001.60%	0.62	2.55	N/A	N/A	N/A
RGLS	REGULUS THERAPEUTICS INC	$528.62M	-50.30%	-46.80%	-60.25%	-70.50%	0.10	10.98	N/A	N/A	N/A
KOD	KODIAK SCIENCES INC	$229.98M	-89.10%	-45.60%	-56.84%	-79.10%	1.23	6.72	N/A	N/A	N/A
CING	CINGULATE INC	$15.86M	-241.10%	-159.20%	-157.15%	-586.50%	0.99	2.55	N/A	N/A	N/A
HOTH	HOTH THERAPEUTICS INC	$11.84M	-103.80%	-94.80%	-118.99%	6,030.30%	0.12	9.20	N/A	N/A	N/A
MIST	MILESTONE PHARMACEUTICALS INC	$70.43M	-152.30%	-48.40%	-56.31%	-32.00%	4.74	9.10	N/A	N/A	N/A
ALT	ALTIMMUNE INC	$404.32M	-65.30%	-58.60%	-73.77%	-95.40%	0.13	13.11	100.00%	-475,295.00%	-475,250.00%
GLPG	GALAPAGOS NV	$1.77B	N/A	N/A	N/A	N/A	0.46	7.95	N/A	N/A	N/A
OTLK	OUTLOOK THERAPEUTICS INC	$50.27M	N/A	-123.20%	140.00%	-6,077.60%	-1.34	0.33	N/A	N/A	N/A
SCPH	SCPHARMACEUTICALS INC	$128.22M	-437.50%	-90.50%	-83.74%	-104.10%	7.07	7.12	68.70%	-234.40%	-213.53%
CYBN	CYBIN INC	$134.41M	-39.00%	-37.70%	-43.25%	-841.30%	0.06	12.60	N/A	N/A	N/A
SYRE	SPYRE THERAPEUTICS INC	$918.00M	-60.70%	-42.60%	-37.51%	-62.00%	0.18	11.26	N/A	N/A	N/A
ENGN	ENGENE HOLDINGS INC	$211.05M	-27.70%	-24.30%	-24.19%	-61.20%	0.14	17.16	N/A	N/A	N/A
OCS	OCULIS HOLDING AG	$759.73M	-95.20%	-71.00%	-112.06%	-177.20%	0.64	2.37	100.00%	-12,503.90%	-12,434.11%
TYRA	TYRA BIOSCIENCES INC	$546.83M	-23.50%	-22.40%	-24.78%	-35.80%	0.06	23.81	N/A	N/A	N/A
NUVL	NUVALENT INC	$5.50B	-29.80%	-28.10%	-23.90%	-36.50%	0.07	20.96	N/A	N/A	N/A
PROK	PROKIDNEY CORP	$259.33M	N/A	-13.60%	-15.26%	-20.30%	-0.04	10.93	100.00%	-80,507.90%	-81,282.89%
LTRN	LANTERN PHARMA INC	$37.96M	-72.60%	-63.40%	-97.84%	-121.00%	0.21	5.83	N/A	N/A	N/A
TRML	TOURMALINE BIO INC	$442.05M	-22.30%	-21.80%	-24.40%	-27.10%	0.03	30.18	N/A	N/A	N/A
ONCY	ONCOLYTICS BIOTECH INC	$45.69M	-225.20%	-114.00%	-233.93%	-11,950.80%	2.37	2.82	N/A	N/A	N/A
KALV	KALVISTA PHARMACEUTICALS INC	$684.58M	-106.80%	-80.60%	-67.41%	-128.10%	0.90	10.44	N/A	N/A	N/A
ATXS	ASTRIA THERAPEUTICS INC	$291.20M	-27.40%	-26.00%	-29.16%	-37.50%	0.07	17.49	N/A	N/A	N/A
CRNX	CRINETICS PHARMACEUTICALS INC	$3.11B	-30.90%	-27.90%	-21.70%	-39.90%	0.08	23.05	100.00%	-28,720.70%	-28,720.69%
CGEM	CULLINAN THERAPEUTICS INC	$484.49M	-29.20%	-27.90%	-28.29%	-34.50%	0.05	13.53	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$1.49B	-39.30%	-33.10%	-22.93%	-32.90%	0.14	25.67	N/A	N/A	N/A
ORKA	ORUKA THERAPEUTICS INC	$390.88M	-42.30%	-38.00%	-21.48%	-107.20%	0.04	28.89	N/A	N/A	N/A
MURA	MURAL ONCOLOGY PLC	$45.31M	-68.20%	-59.00%	-89.75%	-145.60%	0.21	5.84	N/A	N/A	N/A
CRDF	CARDIFF ONCOLOGY INC	$182.28M	-74.00%	-60.60%	-54.24%	-122.60%	0.17	7.08	100.00%	-6,655.20%	-6,651.68%
QSI	QUANTUM-SI INC	$208.78M	-44.30%	-39.70%	-43.95%	-49.60%	0.15	11.99	52.30%	-3,303.00%	-3,301.21%
CADL	CANDEL THERAPEUTICS INC	$231.93M	-468.80%	-118.60%	-76.56%	-2,849.50%	0.61	2.77	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$126.34M	-69.00%	-64.00%	-84.86%	-145.20%	0.10	10.51	N/A	N/A	N/A
ACLX	ARCELLX INC	$3.57B	-22.30%	-14.40%	-23.48%	-24.00%	0.56	4.78	100.00%	-99.50%	-127.46%
DNTH	DIANTHUS THERAPEUTICS INC	$701.94M	-23.90%	-23.00%	-23.90%	-46.60%	0.06	15.22	100.00%	-1,362.80%	-1,362.77%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$347.40M	-31.60%	-21.30%	-34.51%	-899.50%	0.43	4.67	100.00%	-53.10%	-63.12%
CCCC	C4 THERAPEUTICS INC	$116.42M	-43.70%	-28.00%	-34.55%	-32.70%	0.62	5.71	100.00%	-296.00%	-295.60%
EDIT	EDITAS MEDICINE INC	$136.91M	-113.40%	-63.50%	-95.00%	-96.00%	1.54	3.75	100.00%	-733.70%	-777.23%
HOWL	WEREWOLF THERAPEUTICS INC	$40.43M	-73.40%	-47.10%	-58.93%	-137.60%	0.73	7.45	100.00%	-3,740.80%	-3,493.85%
REPL	REPLIMUNE GROUP INC	$753.20M	-54.80%	-43.00%	-39.56%	-50.50%	0.25	11.43	N/A	N/A	N/A
BCYC	BICYCLE THERAPEUTICS PLC	$592.37M	-23.70%	-19.00%	-19.34%	-323.70%	0.21	13.81	100.00%	-479.20%	-487.78%
SGMT	SAGIMET BIOSCIENCES INC	$111.07M	-26.00%	-25.40%	-29.25%	-66.40%	0.03	34.30	N/A	N/A	N/A
ZURA	ZURA BIO LTD	$105.30M	-35.10%	-28.00%	-32.75%	338.60%	0.13	9.16	N/A	N/A	N/A
ELDN	ELEDON PHARMACEUTICALS INC	$189.23M	-55.60%	-29.30%	-21.56%	-35.50%	0.50	12.42	N/A	N/A	N/A
GLSI	GREENWICH LIFESCIENCES INC	$134.06M	-341.10%	-278.70%	-623.07%	1,523.70%	0.62	2.63	N/A	N/A	N/A
ALLR	ALLARITY THERAPEUTICS INC	$20.42M	-263.80%	-117.20%	-205.26%	312.30%	0.92	2.06	N/A	N/A	N/A
QURE	UNIQURE NV	$798.17M	-327.10%	-35.40%	-33.57%	-21.60%	-83.43	9.74	32.40%	-883.40%	-639.35%
CUE	CUE BIOPHARMA INC	$46.67M	-172.10%	-93.90%	-215.53%	-979.40%	0.84	1.84	100.00%	-438.00%	-429.40%
AURA	AURA BIOSCIENCES INC	$292.81M	-47.80%	-41.30%	-51.80%	-46.00%	0.20	10.77	N/A	N/A	N/A
OKUR	ONKURE THERAPEUTICS INC	$33.46M	-62.70%	-59.20%	-50.18%	-184.30%	0.11	10.73	N/A	N/A	N/A
STTK	SHATTUCK LABS INC	$47.37M	-72.60%	-63.10%	-91.82%	-150.40%	0.14	8.88	100.00%	-1,318.10%	-1,318.13%
SKYE	SKYE BIOSCIENCE INC	$67.52M	-35.90%	-31.60%	-37.72%	755.00%	0.07	16.32	N/A	N/A	N/A
GRI	GRI BIO INC	$956.15k	-266.10%	-177.40%	-247.21%	988.10%	0.42	3.43	N/A	N/A	N/A
PCVX	VAXCYTE INC	$4.61B	-17.40%	-16.50%	-13.76%	-22.10%	0.06	12.76	N/A	N/A	N/A
XBIT	XBIOTECH INC	$92.68M	-19.80%	-18.10%	-20.52%	-183.90%	0.09	11.56	N/A	N/A	N/A
PRQR	PROQR THERAPEUTICS NV	$174.65M	-61.30%	-21.50%	-20.83%	-298.30%	0.90	3.96	100.00%	-142.00%	-137.51%
ORIC	ORIC PHARMACEUTICALS INC	$405.56M	-44.50%	-40.70%	-51.28%	-53.00%	0.13	10.56	N/A	N/A	N/A
LXEO	LEXEO THERAPEUTICS INC	$130.46M	-65.10%	-54.20%	-79.13%	-380.70%	0.26	5.52	N/A	N/A	N/A
UBX	UNITY BIOTECHNOLOGY INC	$19.45M	-273.70%	-65.20%	-129.23%	-60.60%	-149.03	1.95	N/A	N/A	N/A
SLNO	SOLENO THERAPEUTICS INC	$3.43B	-75.30%	-63.90%	-56.25%	-84.20%	0.35	15.68	N/A	N/A	N/A
KYMR	KYMERA THERAPEUTICS INC	$2.23B	-28.70%	-24.20%	-24.57%	-26.40%	0.17	7.53	100.00%	-475.60%	-475.04%
AGEN	AGENUS INC	$73.14M	N/A	-89.70%	-2,250.23%	1,098.40%	-1.63	0.21	99.50%	-219.80%	-105.92%
CTXR	CITIUS PHARMACEUTICALS INC	$6.57M	-54.20%	-38.30%	-51.36%	-58.80%	0.79	0.41	N/A	N/A	N/A
VTYX	VENTYX BIOSCIENCES INC	$94.60M	-48.20%	-44.30%	-51.22%	-58.10%	0.09	17.97	N/A	N/A	N/A
CELC	CELCUITY INC	$421.53M	-77.70%	-44.80%	-47.56%	-35.70%	1.12	7.71	N/A	N/A	N/A
VIGL	VIGIL NEUROSCIENCE INC	$98.01M	-96.50%	-69.80%	-100.85%	-122.60%	0.64	2.95	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: A.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 169.3% over the past year, overperforming other biotech stocks by 246 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 388.6% from Protalix Biotherapeutics's current stock price of $3.07.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 61.89% over the past year, overperforming other biotech stocks by 139 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 61.4% over the past year, overperforming other biotech stocks by 138 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 36.68% from Catalyst Pharmaceuticals's current stock price of $24.29.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.97%, which is 5 percentage points higher than the biotech industry average of 1.92%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.43%, which is 1 percentage points higher than the biotech industry average of 1.92%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.31%, which is -1 percentage points lower than the biotech industry average of 1.92%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.74% in the last day, and up 4.52% over the last week. Regulus Therapeutics was the among the top gainers in the biotechnology industry, gaining 136.8% yesterday.

Regulus Therapeutics shares are trading higher after the company announced it entered into an agreement to be acquired by Novartis AG for $7 in cash per share.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -4.66% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -37.28% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 5.61% in the past year. It has overperformed other stocks in the biotech industry by 82 percentage points.

Are biotech stocks a good buy now?

54.79% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 100.94% over the next year.

1.74% of biotech stocks have a Zen Rating of A (Strong Buy), 4.14% of biotech stocks are rated B (Buy), 42.05% are rated C (Hold), 36.38% are rated D (Sell), and 15.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -162.28x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.